# Study to Determine Interaction Between the Use of Feminizing Hormone Therapy and Antiretroviral Agents Concomitantly Among Transgender Women

> **NCT03620734** · — · COMPLETED · sponsor: **Thai Red Cross AIDS Research Centre** · enrollment: 40 (actual)

## Conditions studied

- PrEP and ART

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03620734
- **Lead sponsor:** Thai Red Cross AIDS Research Centre
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-30
- **Primary completion:** 2019-10-01
- **Final completion:** 2019-10-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03620734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03620734, "Study to Determine Interaction Between the Use of Feminizing Hormone Therapy and Antiretroviral Agents Concomitantly Among Transgender Women". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03620734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*